If you didn't find what you were looking for, try a new search!
ASCPT is excited to host a fully online ASCPT 2021 Annual Meeting! Join the global ASCPT community this spring to hear the latest advancements in clinical pharmacology and translational science. Attend dozens of scientific sessions to hear ground-breaking research from the comfort of your own home, including ASCPT’s popular State of the Art lectures, poster [...]
The ASENT 2021 Annual Meeting is the only unique forum in American Neurology which brings together divergent areas of effort from industry, academia, advocacy, and government on one platform with open dialogue. We are pleased to welcome our faculty who include executive-level biohealth industry leaders, chairs of neurology and clinician-scientists from leading academic institutions from [...]
The ASENT 2020 Annual Meeting features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders. Technological breakthroughs featured include the use of DBS, spinal cord stimulation, genomic-based drug discovery, new drug delivery systems.
Clinilabs Drug Development Corporation, the only global, full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug development, was engaged by a large, clinical-stage biopharmaceutical company to manage a randomized, double-blind, placebo-controlled study of a therapy for patients with acute migraine headache. The pivotal trial, involving 100 sites, various demographics and [...]
The 2020 ASCP Annual Meeting will be held in Miami Beach, Florida from May 26 - 29, 2020. The meeting includes representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry that will discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes [...]
Recent years have seen a steady increase in the new applications of somatic therapies that target symptom change in interaction with psychotherapeutic interventions. Examples range from use of repetitive transcranial magnetic stimulation combined with symptom provocation for obsessive compulsive disorder, to intranasal oxytocin combined with social cognition training for young people with early psychosis, to [...]
As the largest gathering on epilepsy in the world, the American Epilepsy Society's Annual Meeting is the event for epilepsy professionals in academia, clinical practice, industry, and advocacy. The American Epilepsy Society welcomes its members and the broader epilepsy community to its Annual Meeting each year. While the primary purpose of the meeting is to [...]
The 2019 ASCP Annual Meeting will be held in Scottsdale, Arizona from May 28-31, 2019. The meeting will include representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry that will discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized [...]
Exhibit Booth #2 The American Society for Clinical Pharmacology and Therapeutics will bring together around 1,400 clinical pharmacologists, translational scientists, and educators to share research, knowledge, and experiences. State of the Art Lectures, which will present the “From Molecule to Patient” theme from various perspectives, including Pharma, Biotech, and Global Health; Innovation Forum, an interactive [...]
About Us Clinilabs is the only global, full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug development. With deep expertise in CNS, we are committed to the development of medicines that treat a range of psychiatric, neurological, and substance use disorders, as well as rare and ultra-rare CNS diseases. [...]
